---
document_datetime: 2025-12-19 12:07:11
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.2543554
conversion_datetime: 2025-12-30 02:12:53.643919
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Yargesa

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | B.II.f.1 Change in the shelf-life or storage | 19/12/2025                          |                                             | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000310253   | conditions of the finished product - B.II.f.1.e Change to an approved stability protocol - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |     | Labelling and PL   |                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|-------------------|
| Variation type IB / | This was an application for a group of variations. B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition) - Accepted | 11/11/2025 | N/A |                    | EMA/VR/0000306901 |
| Variation type II / | B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 11/09/2025 | N/A |                    | EMA/VR/0000262116 |

<div style=\"page-break-after: always\"></div>

|                                       | substance or change in the manufacturer (including where relevant quality control testing sites) of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.b Introduction of a manufacturer of the active substance supported by an ASMF - Accepted                                                                                                                                                                                                                                                                                                        |            |     |             |                                                                                                                                                                                                                                                              |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000275157 | C.I.2 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of a generic/hybrid/biosimilar medicinal products following assessment of the same change for the reference product - C.I.2.a Implementation of change(s) for which no new additional data is required to be submitted by the MAH - Accepted C.I.2.a (IB) - To update of section 4.4 of the SmPC with information regarding the fact that cases of Crohn's disease have been reported post-marketing. The PL is updated accordingly. The change follows assessment of the same change for the reference product Zavesca. | 16/06/2025 |     | SmPC and PL | To update of section 4.4 of the SmPC with information regarding the fact that cases of Crohn's disease have been reported post-marketing. The PL is updated accordingly. The change follows assessment of the same change for the reference product Zavesca. |
| Variation type II / EMA/VR/0000254804 | This was an application for a group of variations. B.II.f.1 Change in the shelf-life or storage conditions of the finished product - B.II.f.1.e Change to an approved stability protocol -                                                                                                                                                                                                                                                                                                                                                                                                                       | 08/05/2025 | N/A |             |                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

| Accepted B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.II.d.1.f Deletion of a specification parameter which may have a significant effect on the overall quality of the finished product - Accepted   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|